Startups
WuXi Clinical, a wholly owned subsidiary of WuXi AppTec, is a global Contract Research Organization (CRO) providing a comprehensive range of services in clinical development. We provide Phase I to Phase IV research & Bioequivalence (BE) studies for pharmaceuticals, biologics, and medical devices. With expertise spanning across all major therapeutic areas, we deliver the unique blend of an experienced team combined with data-driven insights and responsiveness for better outcomes. Our forward-thinking approach has allowed us to accelerate a variety of clinical projects ranging from first-in-human products to marketed drugs and devices.
Overview
Location
United States, Texas, Austin
Employees
51-200
Founded date
1999
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 14, 2022 | Will the Taiwan Semiconductor Manufacturing Company of Drugs Be in East Asia? | On Aug. 25, President Biden signed the monumental $52.7 billion CHIPS and Science Act into law. The legislation is aimed to address the semiconductor manufacturing bottleneck in East Asia, namely the near-monopoly held on the industry by th... |
Reviews 0
FAQ about WuXi Clinical
When was WuXi Clinical founded?
WuXi Clinical was founded in 1999.
What has the press written about WuXi Clinical?
Parsers VC has collected 2 articles mentioning WuXi Clinical, among them “Will the Taiwan Semiconductor Manufacturing Company of Drugs Be in East Asia?” (Oct 14, 2022).
Is WuXi Clinical still active?
Yes, WuXi Clinical is active; its latest activity on Parsers VC dates from Apr 11, 2025.